Rachel Bandli’s practice focuses on complex commercial and intellectual property litigation in federal and state courts. Rachel represents global companies, financial institutions, and groundbreaking tech and pharmaceutical firms in a wide range of litigation and appellate proceedings, including matters involving trade secret misappropriation, corporate governance, patent infringement, complex financial products, and real estate and contract disputes.
Rachel has been recognized as a Rising Star by Super Lawyers.
- Astra Asset Management, a London-based asset manager, in a trust instruction proceeding against Goldman Sachs involving Astra’s investment in an Abacus CDO sponsored by Goldman Sachs. Astra, which was seeking to require the distribution of $55 million in collateral appreciation to investors, rather than to Goldman, won two dispositive motions; Goldman Sachs settled with Astra on the eve of trial.
- Pharos Capital in breach of contract, fraud and breach of fiduciary duty lawsuit arising out of investment in health care company, resulting in dismissal of all claims against client prior to discovery.
- Zydus in two Hatch-Waxman patent infringement actions involving a generic version of INVOKANA® and INVOKAMET®.